The WHO prequalifies a medicine against arthritis

The World Organization of Santé (WHO) has announced that it has been recommended to prequalify tocilizumab, used for the treatment of polyarthrite rhumatoïde, to care for patients with severe forms of Covid-19, in order to provide more accessible medical care. . Le tocilizumab, monoclonal anticorps entrant dans la composition d’un Médicament du géant pharmaceutique Suisse … Read more